Unione Europea - islandese - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - hemophilia b - antihemorrhagics - meðferð og fyrirbyggja blæðingar í sjúklinga með dreyrasýki b (meðfædda þáttur laga skort). , refixia can be used for all age groups.

Unione Europea - islandese - EMA (European Medicines Agency)

roche registration limited - emicizumab - hemophilia a - antihemorrhagics - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra hægt er að nota í öllum aldri tekur.

Unione Europea - islandese - EMA (European Medicines Agency)

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 300 mg

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 75 mg

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

glaxosmithkline pharma a/s - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid - stungulyf, dreifa - áfyllt sprauta

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg

Islanda - islandese - LYFJASTOFNUN (Icelandic Medicines Agency)

roche pharmaceuticals a/s - benserazidum hýdróklóríð; levodopum inn - hart hylki - 100 mg og 25 mg